Literature DB >> 28911884

Anti-VEGF treatment improves neurological function in tumors of the nervous system.

Na Zhang1, Jie Chen1, Gino B Ferraro1, Limeng Wu1, Meenal Datta2, Rakesh K Jain1, Scott R Plotkin3, Anat Stemmer-Rachamimov4, Lei Xu5.   

Abstract

Research of various diseases of the nervous system has shown that VEGF has direct neuroprotective effects in the central and peripheral nervous systems, and indirect effects on improving neuronal vessel perfusion which leads to nerve protection. In the tumors of the nervous system, VEGF plays a critical role in tumor angiogenesis and tumor progression. The effect of anti-VEGF treatment on nerve protection and function has been recently reported - by normalizing the tumor vasculature, anti-VEGF treatment is able to relieve nerve edema and deliver oxygen more efficiently into the nerve, thus reducing nerve damage and improving nerve function. This review aims to summarize the divergent roles of VEGF in diseases of the nervous system and the recent findings of anti-VEGF therapy in nerve damage/regeneration and function in tumors, specifically, in Neurofibromatosis type 2 associated schwannomas.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Anti-VEGF treatment; Neurological function; Schwannoma

Mesh:

Substances:

Year:  2017        PMID: 28911884     DOI: 10.1016/j.expneurol.2017.09.008

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  6 in total

1.  Atorvastatin combined with routine therapy on HIF-1, VEGF concentration and cardiac function in rats with acute myocardial infarction.

Authors:  Jingbin Yu; Lei Zhang; Hui Zhang
Journal:  Exp Ther Med       Date:  2020-01-27       Impact factor: 2.447

2.  The relationship between the degree of brain edema regression and changes in cognitive function in patients with recurrent glioma treated with bevacizumab and temozolomide.

Authors:  Xianglian Wang; Di Chen; Jianjian Qiu; Shihong Li; Xiangpeng Zheng
Journal:  Quant Imaging Med Surg       Date:  2021-11

Review 3.  Immunotherapy in CNS cancers: the role of immune cell trafficking.

Authors:  Nivedita M Ratnam; Mark R Gilbert; Amber J Giles
Journal:  Neuro Oncol       Date:  2019-01-01       Impact factor: 12.300

4.  Concurrent Schwannoma and Meningioma Arising in the Same Spinal Level: A Report of Two Cases.

Authors:  Shingo Matsuda; Yosuke Kajihara; Masaru Abiko; Takafumi Mitsuhara; Masaaki Takeda; Vega Karlowee; Satoshi Yamaguchi; Vishwa Jeet Amatya; Kaoru Kurisu
Journal:  NMC Case Rep J       Date:  2018-09-13

Review 5.  Engineered T Cell Therapy for Cancer in the Clinic.

Authors:  Lijun Zhao; Yu J Cao
Journal:  Front Immunol       Date:  2019-10-11       Impact factor: 7.561

6.  Melatonin ameliorates microvessel abnormalities in the cerebral cortex and hippocampus in a rat model of Alzheimer's disease.

Authors:  Pan Wang; Hai-Juan Sui; Xiao-Jia Li; Li-Na Bai; Jing Bi; Hong Lai
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.